Search research articles
Contact Us
Filters
Showing results (581-590 of 613) with videos related to
Page
of 62
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
American Journal of Human Genetics
|
November 26, 2013
Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice
Adel Shalata, Maria C Ramirez, Robert J Desnick, et al.
Molecular Therapy. Methods & Clinical Development
|
September 13, 2021
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment
Susana Navarro, Oscar Quintana-Bustamante, Rebeca Sanchez-Dominguez, et al.
The Oncologist
|
May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial
Julia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Gastroenterology
|
August 19, 2007
Five-year colon surveillance after screening colonoscopy
David A Lieberman, David G Weiss, William V Harford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
D Williams Parsons, Katherine A Janeway, David R Patton, et al.
Gynecologic Oncology
|
November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Casey M Cosgrove, David L Tritchler, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group
Florette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Journal of the National Cancer Institute
|
May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
Susan N Chi, Joanna S Yi, P Mickey Williams, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 613) with videos related to
Sort By:
Page
of 62
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
American Journal of Human Genetics
|
November 26, 2013
Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice
Adel Shalata, Maria C Ramirez, Robert J Desnick, et al.
Molecular Therapy. Methods & Clinical Development
|
September 13, 2021
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment
Susana Navarro, Oscar Quintana-Bustamante, Rebeca Sanchez-Dominguez, et al.
The Oncologist
|
May 30, 2024
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial
Julia L Glade Bender, Kerice Pinkney, Paul M Williams, et al.
Gastroenterology
|
August 19, 2007
Five-year colon surveillance after screening colonoscopy
David A Lieberman, David G Weiss, William V Harford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2022
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial
Olive S Eckstein, Carl E Allen, P Mickey Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 30, 2022
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
D Williams Parsons, Katherine A Janeway, David R Patton, et al.
Gynecologic Oncology
|
November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer
Casey M Cosgrove, David L Tritchler, David E Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group
Florette K Hazard, Angus M S Toland, Serena Y Tan, et al.
Journal of the National Cancer Institute
|
May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
Susan N Chi, Joanna S Yi, P Mickey Williams, et al.
Page
of 62